Hassel v. Franzi, 311 EDA 2018
Decision Date | 08 April 2019 |
Docket Number | No. 311 EDA 2018,311 EDA 2018 |
Citation | 207 A.3d 939 |
Parties | Robert HASSEL, both Individually and in His Capacity as Administrator of the Estate of Mary Hassel, Deceased, Appellant v. Joseph J. FRANZI, Md, PhD: Frankford Avenue Family Practice, P.C., d/b/a Frankford Avenue Family Practice William V. Arnold, Md, PhD Reconstructive Orthopaedic Associates, II, P.C. d/b/a/ the Rothman Institute |
Court | Pennsylvania Superior Court |
H. Leon Aussprung, III, Philadelphia, for appellant.
Kevin H. Wright, Lansdale, and Maureen M. McBride, West Chester, for Franzi, appellee.
Paul E. Peel, Plymouth Meeting, for Arnold, appellee.
BEFORE: OLSON, J., DUBOW, J., and STEVENS* , P.J.E.
Appellant in this medical malpractice case Robert Hassel, both individually and in his capacity as administrator of the estate of Mary Hassel, deceased (hereinafter "Appellant") appeals from the judgment entered in the Court of Common Pleas of Philadelphia County on February 16, 2018, in favor of Appellees Joseph J. Franzi, M.D., Ph.D. and Frankford Avenue Family Practice, P.C., D/B/A/ Frankford Avenue Family Practice (hereinafter "Dr. Franzi") and William V. Arnold, M.D., Ph.D. and Reconstructive Orthopaedic Associates, II, P.C. D/B/A the Rothman Institute (hereinafter "Dr. Arnold") (hereinafter collectively "Appellees"). Following a careful review, we affirm.
The trial court set forth the relevant facts and procedural history herein as follows:
("herein DVT") and Pulmonary Embolism. Specifically, [Appellant] alleged that Dr. Arnold failed to ensure that Mrs. Hassel was prescribed appropriate medication to prevent blot clots. Because of her risk factors for DVT, [Appellant] argued that Mrs. Hassel should have been prescribed an anticoagulant drug like coumadin, instead of aspirin, which is an antiplatelet drug. Dr. Franzi, her primary care physician, was accused of prescribing the wrong medication and failing to return voicemail messages from Mrs. Hassel's husband on the day she died, which [Appellant] alleged described symptoms of DVT that Dr. Franzi should have recognized. [Appellant] also contended that Mrs. Hassel's life could have been saved if Dr. Franzi would have returned her husband[']s phone calls on July 1, 2013.
, osteoarthritis, thyroid disease, and a BMI of 41.6 at the time she sought treatment. N.T. December 8, 2017, p.m., pp. 78-80. Dr. Arnold ordered a STAT MRI and the results showed a fracture of Mrs. Hassel's femur. Id. at 95-97. He determined that surgery was not necessary and recommended immobilizing Mrs. Hassel's left leg to facilitate healing. Id. at 99. Dr. Arnold's plan was to replace her knee only after the femur healed. Id. at 109.
That same day, Dr. Arnold notified Mrs. Hassel of the MRI results by telephone and she opted to see Dr. Arnold again in 2 days as opposed to going immediately to the emergency room. Id. at 97-99. Blood clot prevention was discussed with Mrs. Hassel and coumadin was mentioned as an option. N.T. December 6, 2017, p.m., pp. 16. Mrs. Hassel was familiar with coumadin and understood that taking it requires additional diagnostic monitoring. Id. Dr. Arnold also told Mrs. Hassel that he would contact her primary care physician, Dr. Franzi, to discuss blood clot prevention treatment due to her being immobilized while the fracture heals. December 8, 2017, p.m., pp. 102. After speaking to Mrs. Hassel, Dr. Arnold contacted Dr. Franzi to discuss the findings of the MRI and her potential risk factors for blood clots. Id. at 103. The two physicians agreed that Dr. Franzi would select the course of treatment for Mrs. Hassel based on his existing relationship with her and extensive knowledge about her medical history. Id. at 106-07. Dr. Arnold's notes from his conversation with Dr. Franzi demonstrated an understanding between the two of them that Dr. Franzi would work on Mrs. Hassel's "anticoagulation." N.T. December 6, 2017, p.m., pp. 82. Dr. Franzi contacted Mrs. Hassel that same day and advised her to take 325 milligrams of aspirin twice per day to prevent blood clots. Dr. Franzi discussed coumadin and aspirin as options to prevent blood clots but did not discuss other drugs. Id. at 92.
caused by the DVT in her left leg and subsequent pulmonary embolism that developed. N.T. December 5, 2017, p.m., pp. 62-63.
[Appellant] presented expert testimony from Dr. David Diuguid, a hematologist, to provide causation opinions and support the contention that, anticoagulant drugs and antiplatelet drugs work differently, and he explained how each category of drugs affect blood coagulation. N.T. December 4, 2017, p.m., pp. 2-7, 39, 41, 45-50.1 Dr. Diuguid alleged that anticoagulant drugs, as opposed to antiplatelet drugs, were more appropriate for Mrs. Hassel due to her risk factors for DVT that Dr. Franzi and Dr. Arnold both knew about. Id. at 26, 59-62. He also testified that Mrs. Hassel likely would not have died, had she been placed on anticoagulant medication. Id. at 58. Dr. Diuguid also provided testimony to support Plaintiff's assertion that Mrs. Hassel's chances for survival would have improved if Dr. Franzi would have told her to go to the emergency room. Id. at 53-57,
[Appellant] also presented expert testimony from Dr. Paul Genecin, an expert in primary care medicine and family practice. N.T. December 5, 2017, a.m., pp. 10. Dr. Genecin testified that Dr. Franzi was aware of Mrs. Hassel's risk factors for DVTs as early as 2005 because her medical records show that he ordered multiple diagnostic tests to check for them. Id. at 21-27. He cites several instances where he felt that Dr. Franzi's treatment of Mrs. Hassel did not meet the standard of care, attacking his clinical record-keeping, choice of blood clot prevention medication, and the fact that Mr. Hassel's phone calls, describing her symptoms on the day she died, went unanswered. Id. at 30-31, 35-43, 45-52. Dr. Genecin concluded by stating that Mrs. Hassel could have been saved if Dr. Franzi would have returned Mr. Hassel's phone call and that his failure to do was a deviation...
To continue reading
Request your trial-
Dobransky v. EQT Production Company
...was raised by the moving party in the trial court, such that the non-moving party had an opportunity to respond. Hassel v. Franzi , 207 A.3d 939, 957 n.6 (Pa.Super. 2019) ; see also , e.g. , Branton v. Nicholas Meat, LLC , 159 A.3d 540, 562 n.21 (Pa.Super. 2017).Turning to Section 302(a)(2)......
-
Nazarak v. Waite
...preparing a meaningful response, or which would mislead the adversary as to the nature of the appropriate response. Hassel v. Franzi , 207 A.3d 939, 951 (Pa.Super. 2019) (quotation and citations omitted). In her expert report dated December 13, 2017, Ms. Evans relevantly indicated the follo......
-
Dobransky v. EQT Prod. Co. & Halliburton Energy Servs.
...... Appellees. On July 2, 2018, Appellees filed a motion for. summary judgment, arguing that they were ... non-moving party had an opportunity to respond. Hassel v. Franzi , 207 A.3d 939, 957 n.6 (Pa.Super. 2019); see. also , e.g. , ......
-
Musselman v. McDonald
...and Order, 9/6/17, at 3. 3. This Court is not limited by the trial court's rationale and may affirm on any basis. Hassel v. Franzi, 207 A.3d 939, 957 (Pa. Super. 2019) (citing Commonwealth v. Moore, 937 A.2d 1062, 1073 (Pa. 2007) (it is a well-settled doctrine in this Commonwealth that a tr......
-
Witness
...opinion was based upon relatively new and untested theory of peripheral nerve damage. PENNSYLVANIA Hassel v. Franzi , 2019 PA Super 109, 207 A.3d 939, appeal denied , 218 A.3d 862 (Pa. 2019). On cross-examination, an expert witness may be questioned on the contents of any publication on whi......